Please login to the form below

human growth hormone

This page shows the latest human growth hormone news and features for those working in and with pharma, biotech and healthcare.

CHMP recommends Teva's generic version of Astellas' Advagraf

The committee also recommended that Faslodex could be used in combination with Pfizer ’s breast cancer drug Ibrance (palbociclib) to treat hormone receptor positive, human epidermal growth factor receptor 2-negative ... The combination can also be used

Latest news

Lilly gets early US approval for Ibrance rival abemaciclib

The US FDA has approved the CDK 4/6 inhibitor - which will be sold as Verzenio - as a combination treatment with hormone drug fulvestrant for hormone receptor-positive, human epidermal growth
Versartis crashes as VELOCITY trial veers off track

US biotech Versartis saw more than 80% wiped off its share price ahead of the weekend after its growth hormone deficiency drug somavaratan failed a phase III trial. ... The long-acting human growth hormone (hGH) product had been billed as a successor to
Surging Trulicity takes sting out of Lilly's arthritis setback

New chief executive David Ricks needs the drug and other growth brands to fire on all cylinders to help Lilly ride through the recent disappointment of a surprise FDA rejection for ... receptor-positive (HR+), human epidermal growth factor receptor
Pfizer keeps nose ahead of rivals with new Ibrance approval

The US FDA has converted its earlier conditional approval of Ibrance (palbociclib) into full approval as a first-line treatment of post-menopausal women with hormone receptor positive, human epidermal growth
FDA approval for Kisqali sets up showdown with Ibrance

menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer.

More from news
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest Intelligence

Implementing eHealth innovation

Medications management and eHealth. The reference treatment for patients with GHD is based on recombinant human growth hormone (rhGH) which is identical to the growth hormone produced by the pituitary gland. ... growth hormone deficiency, one in which
Pharma deals during December 2014

costs. Pfizer has also signed up to a drug delivery product this month through its $570m licensing deal with Opko Health for a long acting version of human growth hormone (hGH), ... which is currently in phase III trials for the treatment of growth

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Pharma and free medicines: a different perspective

Palbociclib is approved for the treatment of patients with locally advanced or metastatic breast cancer, specifically those who have hormone receptor-positive and human epidermal growth factor receptor 2-negative disease. ... The committee found that

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Associate Director: £75, 000-90, 000

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Senior Account Director development role to Business Director, H...: Excellent package

Senior Medical Writer (Remote Working): Competitive Salary Offered

Senior Account Executive, London, Medical Communications: Excellent package

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Director, Market Access / HEOR - North-West: Negotiable

Medical Writers Required – Cheshire: DOE

Associate Editorial Director – Med Comms – London: Salary TBC

Consumer Health Account Director: Circa £60, 000 Gym and More

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Senior Medical Writer: Great salary and benefits

Project / Account Manager (Medical Education): Salary TBC

Production Manager – Healthcare Communications: DOE

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Scientific Director / Editorial Team Leader: Great salary and benefits

Senior Account Manager: Negotiable

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Associate Director, Market Access & HEOR – North-West: Negotiable

Consultant Health Economics - London / Oxford: Negotiable

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Account Director: Excellent benefits

Associate Medical Director: Highly Competitive

Subscribe to our email news alerts

PMHub

Add my company

ben.quarless@publicishealth.com

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health: For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
Innovation in merger control and the impact on the pharmaceutical sector: Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think: Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...